820
Participants
Start Date
November 30, 2008
Primary Completion Date
July 31, 2010
Study Completion Date
January 31, 2011
exenatide once weekly
subcutaneous injection, 2mg, once weekly plus placebo oral once daily
metformin
oral, 1000-2500mg, daily plus placebo once weekly subcutaneous injection
sitagliptin
oral, 100 mg, daily plus placebo once weekly subcutaneous injection
pioglitazone
oral, 30-45mg, daily plus placebo once weekly subcutaneous injection
Research Site, Buena Park
Research Site, Los Angeles
Research Site, Valencia
Research Site, Jacksonville
Research Site, Atlanta
Research Site, Meridian
Research Site, Des Moines
Research Site, Grand Rapids
Research Site, Minneapolis
Research Site, Billings
Research Site, Toms River
Research Site, Wilmington
Research Site, Danville
Research Site, Philadelphia
Research Site, Wilke Barre
Research Site, Austin
Research Site, El Paso
Research Site, New Branufels
Research Site, Buenos Aires
Research Site, Mar del Plata
Research Site, Leuven
Research Site, Marchovelette
Research Site, Tessenderlo
Research Site, Brasília
Research Site, Campinas
Research Site, Curitiba
Research Site, Fortaleza
Research Site, Joinville
Research SIte, Porto Alegre
Research Site, Recife
Research Site, São Paulo
Research Site, Coquitlam
Research Site, Penticton
Research Site, Ottawa
Research Site, Gatineu
Research Site, Mississauga
Research Site, Petitcodiac
Research Site, Pointe-Claire
Research Site, Regina
Research Site, Saint John
Research Site, Châteaugiron
Research Site, Mûrs-Erigné
Research Site, Nantes
Research Site, Vieux-Condé
Research Site, Dresden
Research Site, Mainz
Research Site, Münster
Research Site, Rodgau
Research Site, Budapest
Research Site, Gyula
Research Site, Hódmezővásárhely
Research Site, Pécs
Research Site, Ahmedabad
Research Site, Bangalore
Research Site, Channai
Research Site, Kochi
Research Site, Mumbai
Research Site, New Dehli
Research SIte, Pune
Research Site, Holon
Research SIte, Tel Litwinsky
Research Site, Florence
Research Site, Milan
Research Site, Siena
Research Site, Chihuahua City
Research Site, Guadalajara
Research Site, Monterrey
Research Site, Lublin
Research Site, Szczecin
Research Site, Wroclaw
Research Site, Manatí
Research Site, Toa Baja
Research Site, Galati
Research Site, Oradea
Research Site, Târgu Mureş
Research Site, Arkhangelsk
Research Site, Moscow
Research Site, Rostov-on-Don
Research Site, Saint Petersburg
Research Site, Stavropol
Research Site, Bratislava
Research Site, Trebišov
Research Site, Johannesburg
Research Site, Kempton Park
Research Site, Midrand
Research Site, Soweto
Research Site, Busan
Research Site, Daegu
Research Site, Jeonju
Research Site, Seoul
Research Site, Sungnam
Research Site, Alicante
Research Site, Barcelona
Research Site, Madrid
Research Site, Seville
Research Site, Ankara
Research Site, Istanbul
Research Site, Sisli-Istanbul
Research Site, Bath
Research Site, Birmingham
Research Site, Edinburgh
Research Site, Frome
Research Site, Guildford
Research Site, Hull
Research Site, Sheffield
Research Site, Swansea
Lead Sponsor
Eli Lilly and Company
INDUSTRY
AstraZeneca
INDUSTRY